Rheumatoid Arthritis And Shingles.
The newest medications old to scrutinize autoimmune diseases such as rheumatoid arthritis don't appear to raise the risk of developing shingles, experimental research indicates. There has been concern that these medications, called anti-tumor necrosis factor (anti-TNF) drugs, might prolong the chances of a shingles infection (also known as herpes zoster) because they create by suppressing a part of the immune system that causes the autoimmune attack. "These are commonly in use drugs for people with rheumatoid arthritis and other autoimmune diseases, and the issue was whether or not they increased the risk of shingles.
We found there is no increased hazard when using these drugs, which was reassuring," said study author Dr Kevin Winthrop, friend professor of infectious disease and public health and preventive medicine at Oregon Health and Science University in Portland. Results of the contemplate are published in the March 6 issue of the Journal of the American Medical Association.
Shingles is a paramount concern for people with autoimmune conditions, particularly occupy who are older and more at risk for developing shingles in general. Shingles is caused when the same virus that causes chickenpox is reactivated. The symptoms of shingles, however, are often far more genuine than chickenpox. It typically starts with a ardent or tingling pain, which is followed by the appearance of fluid-filled blisters, according to the US National Institutes of Neurological Disorders and Stroke.
Shingles soreness can vary from mild to so severe that even the lightest touch causes excessive pain. People who have rheumatoid arthritis already have an increased risk of shingles, although Winthrop said it's not specifically clear why. It may be due to older age, or it may have something to do with the disease itself. Rheumatoid arthritis and other autoimmune conditions are treated with many unlike medications that help dampen the immune set and, hopefully, the autoimmune attack.
Wednesday, 8 January 2020
Very Loud Music Can Cause Hearing Loss In Adolescence
Very Loud Music Can Cause Hearing Loss In Adolescence.
Over the finish two decades hearing sacrifice due to "recreational" noise exposure such as blaring blackjack music has risen among adolescent girls, and now approaches levels previously seen only amid adolescent boys, a new study suggests. And teens as a whole are increasingly exposed to snazzy noises that could place their long-term auditory health in jeopardy, the researchers added. "In the '80s and dawn '90s young men experienced this kind of hearing damage in greater numbers, undoubtedly as a reflection - of what young men and young women have traditionally done for farm and fun," noted study lead author Elisabeth Henderson, an MD-candidate in Harvard Medical School's School of Public Health in Boston.
And "This means that boys have usually been faced with a greater caste of risk in the form of occupational noise exposure, fire alarms, lawn mowers, that sympathetic of thing. But now we're seeing that young women are experiencing this same level of damage, too". Henderson and her colleagues piece their findings in the Dec 27, 2010 online version of Pediatrics.
To explore the risk for hearing damage among teens, the authors analyzed the results of audiometric testing conducted centre of 4,310 adolescents between the ages of 12 and 19, all of whom participated in the US National Health and Nutrition Examination Surveys. Comparing booming noise uncovering across two periods of time (from 1988 to 1994 and from 2005 to 2006), the line-up determined that the degree of teen hearing loss had generally remained relatively stable. But there was one exception: teen girls.
Between the two investigate periods, hearing loss due to loud disturbance exposure had gone up among adolescent girls, from 11,6 percent to 16,7 percent - a plain that had previously been observed solely among adolescent boys. When asked about their past day's activities, look at participants revealed that their overall exposure to loud noise and/or their use of headphones for music-listening had rocketed up, from just under 20 percent in the overdue 1980s and early 1990s to nearly 35 percent of adolescents in 2005-2006.
Over the finish two decades hearing sacrifice due to "recreational" noise exposure such as blaring blackjack music has risen among adolescent girls, and now approaches levels previously seen only amid adolescent boys, a new study suggests. And teens as a whole are increasingly exposed to snazzy noises that could place their long-term auditory health in jeopardy, the researchers added. "In the '80s and dawn '90s young men experienced this kind of hearing damage in greater numbers, undoubtedly as a reflection - of what young men and young women have traditionally done for farm and fun," noted study lead author Elisabeth Henderson, an MD-candidate in Harvard Medical School's School of Public Health in Boston.
And "This means that boys have usually been faced with a greater caste of risk in the form of occupational noise exposure, fire alarms, lawn mowers, that sympathetic of thing. But now we're seeing that young women are experiencing this same level of damage, too". Henderson and her colleagues piece their findings in the Dec 27, 2010 online version of Pediatrics.
To explore the risk for hearing damage among teens, the authors analyzed the results of audiometric testing conducted centre of 4,310 adolescents between the ages of 12 and 19, all of whom participated in the US National Health and Nutrition Examination Surveys. Comparing booming noise uncovering across two periods of time (from 1988 to 1994 and from 2005 to 2006), the line-up determined that the degree of teen hearing loss had generally remained relatively stable. But there was one exception: teen girls.
Between the two investigate periods, hearing loss due to loud disturbance exposure had gone up among adolescent girls, from 11,6 percent to 16,7 percent - a plain that had previously been observed solely among adolescent boys. When asked about their past day's activities, look at participants revealed that their overall exposure to loud noise and/or their use of headphones for music-listening had rocketed up, from just under 20 percent in the overdue 1980s and early 1990s to nearly 35 percent of adolescents in 2005-2006.
Doctors Strongly Recommend That All Pregnant Women To Have A Blood Test For HIV
Doctors Strongly Recommend That All Pregnant Women To Have A Blood Test For HIV.
A babe born two-and-a-half years ago in Mississippi with HIV is the basic casing of a so-called "functional cure" of the infection, researchers announced Sunday. Standard tests can no longer spot any traces of the AIDS-causing virus even though the child has discontinued HIV medication. "We allow this is the first well-documented case of a functional cure," said look lead author Dr Deborah Persaud, associate professor of pediatrics in the class of infectious diseases at Johns Hopkins Children's Center in Baltimore. The finding was presented Sunday at the Conference on Retroviruses and Opportunistic Infections, in Atlanta.
The lass was not part of a study but, instead, the beneficiary of an unexpected and partly unplanned cycle of events that - once confirmed and replicated in a strict study - might help more children who are born with HIV or who at risk of contracting HIV from their parent eradicate the virus from their body. Normally, mothers infected with HIV take antiretroviral drugs that can almost murder the odds of the virus being transferred to the baby. If a mother doesn't be familiar with her HIV status or hasn't been treated for other reasons, the baby is given "prophylactic" drugs at birth while awaiting the results of tests to infer his or her HIV status.
This can take four to six weeks to complete. If the tests are positive, the child starts HIV drug treatment. The fuss over of the baby born in Mississippi didn't know she was HIV-positive until the time of delivery.
But in this case, both the primary and confirmatory tests on the baby were able to be completed within one day, allowing the baby to be started on HIV medicine treatment within the first 30 hours of life. "Most of our kids don't get picked up that early". As expected, the baby's "viral load" - detectable levels of HIV - decreased progressively until it was no longer detectable at 29 days of age.
Theoretically, this young gentleman (doctors aren't disclosing the gender) would have bewitched the medications for the lay of his or her life, said the researchers, who included doctors from the University of Massachusetts Medical School and the University of Mississippi Medical Center. Instead, the toddler stayed on the regimen for only 18 months before dropping out of the medical combination and discontinuing the drugs.
Ten months after stopping treatment, however, the youth was again seen by doctors who were surprised to find no HIV virus or HIV antibodies with customary tests. Ultrasensitive tests did detect infinitesimal traces of viral DNA and RNA in the blood. But the virus was not replicating - a influentially unusual occurrence given that drugs were no longer being administered, the researchers said.
A babe born two-and-a-half years ago in Mississippi with HIV is the basic casing of a so-called "functional cure" of the infection, researchers announced Sunday. Standard tests can no longer spot any traces of the AIDS-causing virus even though the child has discontinued HIV medication. "We allow this is the first well-documented case of a functional cure," said look lead author Dr Deborah Persaud, associate professor of pediatrics in the class of infectious diseases at Johns Hopkins Children's Center in Baltimore. The finding was presented Sunday at the Conference on Retroviruses and Opportunistic Infections, in Atlanta.
The lass was not part of a study but, instead, the beneficiary of an unexpected and partly unplanned cycle of events that - once confirmed and replicated in a strict study - might help more children who are born with HIV or who at risk of contracting HIV from their parent eradicate the virus from their body. Normally, mothers infected with HIV take antiretroviral drugs that can almost murder the odds of the virus being transferred to the baby. If a mother doesn't be familiar with her HIV status or hasn't been treated for other reasons, the baby is given "prophylactic" drugs at birth while awaiting the results of tests to infer his or her HIV status.
This can take four to six weeks to complete. If the tests are positive, the child starts HIV drug treatment. The fuss over of the baby born in Mississippi didn't know she was HIV-positive until the time of delivery.
But in this case, both the primary and confirmatory tests on the baby were able to be completed within one day, allowing the baby to be started on HIV medicine treatment within the first 30 hours of life. "Most of our kids don't get picked up that early". As expected, the baby's "viral load" - detectable levels of HIV - decreased progressively until it was no longer detectable at 29 days of age.
Theoretically, this young gentleman (doctors aren't disclosing the gender) would have bewitched the medications for the lay of his or her life, said the researchers, who included doctors from the University of Massachusetts Medical School and the University of Mississippi Medical Center. Instead, the toddler stayed on the regimen for only 18 months before dropping out of the medical combination and discontinuing the drugs.
Ten months after stopping treatment, however, the youth was again seen by doctors who were surprised to find no HIV virus or HIV antibodies with customary tests. Ultrasensitive tests did detect infinitesimal traces of viral DNA and RNA in the blood. But the virus was not replicating - a influentially unusual occurrence given that drugs were no longer being administered, the researchers said.
Treatment Of Heart Attack And Stroke In Certified Hospitals
Treatment Of Heart Attack And Stroke In Certified Hospitals.
Around the nation, hospitals pass on to themselves as "stroke centers of excellence" or "chest bore centers," the substance being those facilities offer top-notch care for stroke and heart attacks. But stylish programs for certifying, accrediting or recognizing hospitals as providers of the best cardiovascular or stroke care are falling short, according to an American Heart Association/American Stroke Association advisory. "Right now, it's not always sheer what is just a marketing duration and what actually truly distinguishes the quality of a center," said Dr Gregg Fonarow, an American Heart Association spokesman and professor of cardiovascular medication at the University of California, Los Angeles.
A look at of the available data found no clear relationship between having a festive designation as a heart attack or stroke care center and the care the hospitals provide or, even more important, how patients fare. To variation that, the American Heart Association and the American Stroke Association are jointly developing a inclusive stroke and cardiovascular care certification program that should go through as a national standard.
The goal is to help patients, insurers and others have more reliable data about where they are most likely to receive the most up-to-date, evidence-based care available. "There is a value to having a trusted origin develop a certification program that clinicians, insurers and the public can use to understand which hospitals are providing uncommon cardiovascular and stroke care, including achieving high-quality outcomes".
The program, which will take from about two years to develop and will likely be done in partnership with other major medical organizations, will cover exigency situations such as heart attack and stroke, but also heart failure management and coronary bypass surgery. The admonitory is published online Nov 12, 2010 and in the Dec 7, 2010 language issue of Circulation.
Typically, recognition and certification programs require that hospitals put certain procedures in place, but they don't praepostor how well hospitals are adhering to the practices or whether patient outcomes are improving precedent author of the advisory. And those are the better certification programs. Other self-proclaimed "centers of excellence" may unmistakably be terms dreamed up by marketing departments.
Around the nation, hospitals pass on to themselves as "stroke centers of excellence" or "chest bore centers," the substance being those facilities offer top-notch care for stroke and heart attacks. But stylish programs for certifying, accrediting or recognizing hospitals as providers of the best cardiovascular or stroke care are falling short, according to an American Heart Association/American Stroke Association advisory. "Right now, it's not always sheer what is just a marketing duration and what actually truly distinguishes the quality of a center," said Dr Gregg Fonarow, an American Heart Association spokesman and professor of cardiovascular medication at the University of California, Los Angeles.
A look at of the available data found no clear relationship between having a festive designation as a heart attack or stroke care center and the care the hospitals provide or, even more important, how patients fare. To variation that, the American Heart Association and the American Stroke Association are jointly developing a inclusive stroke and cardiovascular care certification program that should go through as a national standard.
The goal is to help patients, insurers and others have more reliable data about where they are most likely to receive the most up-to-date, evidence-based care available. "There is a value to having a trusted origin develop a certification program that clinicians, insurers and the public can use to understand which hospitals are providing uncommon cardiovascular and stroke care, including achieving high-quality outcomes".
The program, which will take from about two years to develop and will likely be done in partnership with other major medical organizations, will cover exigency situations such as heart attack and stroke, but also heart failure management and coronary bypass surgery. The admonitory is published online Nov 12, 2010 and in the Dec 7, 2010 language issue of Circulation.
Typically, recognition and certification programs require that hospitals put certain procedures in place, but they don't praepostor how well hospitals are adhering to the practices or whether patient outcomes are improving precedent author of the advisory. And those are the better certification programs. Other self-proclaimed "centers of excellence" may unmistakably be terms dreamed up by marketing departments.
Tuesday, 7 January 2020
The Presence Of A Few Extra Pounds In Man Reduces The Risk Of Sudden Death
The Presence Of A Few Extra Pounds In Man Reduces The Risk Of Sudden Death.
A uncharted worldwide opinion reveals a surprising pattern: while obesity increases the risk of dying early, being slightly overweight reduces it. These studies included almost 3 million adults from around the world, yet the results were remarkably consistent, the authors of the scrutiny noted. "For populate with a medical condition, survival is slight better for people who are slightly heavier," said study author Katherine Flegal, a older research scientist at the US Centers for Disease Control and Prevention's National Center for Health Statistics.
Several factors may narrative for this finding. "Maybe heavier people present to the doctor earlier, or get screened more often. Heavier bourgeoisie may be more likely to be treated according to guidelines, or fat itself may be cardioprotective, or someone who is heavier might be more resilient and better able to summer-house a shock to their system". The report was published Jan. 2 in the Journal of the American Medical Association.
For the study, Flegal's body collected data on more than 2,88 million kinsfolk included in 97 studies. These studies were done in the United States, Canada, Europe, Australia, China, Taiwan, Japan, Brazil, Israel, India and Mexico. The researchers looked at the participants' body miscellany index, or BMI, which is a extent of body fat that takes into narration a person's height and weight. Pooling the data from all the studies, the researchers found that compared with normal substance people, overweight people had a 6 percent lower risk of death.
Obese people, however, had an 18 percent higher chance of death. For those who were the least obese, the risk of eradication was 5 percent lower than for normal weight people, but for those who were the most obese the risk of death was 29 percent higher, the findings revealed. While the workroom found an association between weight and premature expiration risk, it did not prove a cause-and-effect relationship.
A uncharted worldwide opinion reveals a surprising pattern: while obesity increases the risk of dying early, being slightly overweight reduces it. These studies included almost 3 million adults from around the world, yet the results were remarkably consistent, the authors of the scrutiny noted. "For populate with a medical condition, survival is slight better for people who are slightly heavier," said study author Katherine Flegal, a older research scientist at the US Centers for Disease Control and Prevention's National Center for Health Statistics.
Several factors may narrative for this finding. "Maybe heavier people present to the doctor earlier, or get screened more often. Heavier bourgeoisie may be more likely to be treated according to guidelines, or fat itself may be cardioprotective, or someone who is heavier might be more resilient and better able to summer-house a shock to their system". The report was published Jan. 2 in the Journal of the American Medical Association.
For the study, Flegal's body collected data on more than 2,88 million kinsfolk included in 97 studies. These studies were done in the United States, Canada, Europe, Australia, China, Taiwan, Japan, Brazil, Israel, India and Mexico. The researchers looked at the participants' body miscellany index, or BMI, which is a extent of body fat that takes into narration a person's height and weight. Pooling the data from all the studies, the researchers found that compared with normal substance people, overweight people had a 6 percent lower risk of death.
Obese people, however, had an 18 percent higher chance of death. For those who were the least obese, the risk of eradication was 5 percent lower than for normal weight people, but for those who were the most obese the risk of death was 29 percent higher, the findings revealed. While the workroom found an association between weight and premature expiration risk, it did not prove a cause-and-effect relationship.
Study Of Helmets With Face Shields
Study Of Helmets With Face Shields.
Adding expression shields to soldiers' helmets could truncate brain damage resulting from explosions, which account for more than half of all combat-related injuries unremitting by US troops, a new study suggests. Using computer models to simulate battlefield blasts and their chattels on brain tissue, researchers learned that the face is the strongest pathway through which an explosion's pressure waves reach the brain. According to the US Department of Defense, about 130000 US repair members deployed in Afghanistan and Iraq have sustained blast-induced injurious brain injury (TBI) from explosions.
The addition of a face shield made with transparent armor statistics to the advanced combat helmets (ACH) worn by most troops significantly impeded direct curse waves to the face, mitigating brain injury, said lead researcher Raul Radovitzky, an confidant professor at the Massachusetts Institute of Technology (MIT). "We tried to assess the physics of the problem, but also the biological and clinical responses, and bind it all together," said Radovitzky, who is also associate chief honcho of MIT's Institute for Soldier Nanotechnologies. "The key thing from our point of view is that we gnome the problem in the news and thought maybe we could make a contribution".
Researching the issue, Radovitzky created computer models by collaborating with David Moore, a neurologist at the Defense and Veterans Brain Injury Center at Walter Reed Army Medical Center in Washington, DC Moore old MRI scans to simulate features of the brain, and the two scientists compared how the brains would reply to a frontal destroy wave in three scenarios: a head with no helmet, a head wearing the ACH, and a prime minister wearing the ACH plus a face shield. The sophisticated computer models were able to fuse the force of blast waves with skull features such as the sinuses, cerebrospinal fluid, and the layers of gray and whey-faced matter in the brain. Results revealed that without the face shield, the ACH slightly delayed the burst wave's arrival but did not significantly lessen its effect on brain tissue. Adding a face shield, however, considerably reduced forces on the brain.
Adding expression shields to soldiers' helmets could truncate brain damage resulting from explosions, which account for more than half of all combat-related injuries unremitting by US troops, a new study suggests. Using computer models to simulate battlefield blasts and their chattels on brain tissue, researchers learned that the face is the strongest pathway through which an explosion's pressure waves reach the brain. According to the US Department of Defense, about 130000 US repair members deployed in Afghanistan and Iraq have sustained blast-induced injurious brain injury (TBI) from explosions.
The addition of a face shield made with transparent armor statistics to the advanced combat helmets (ACH) worn by most troops significantly impeded direct curse waves to the face, mitigating brain injury, said lead researcher Raul Radovitzky, an confidant professor at the Massachusetts Institute of Technology (MIT). "We tried to assess the physics of the problem, but also the biological and clinical responses, and bind it all together," said Radovitzky, who is also associate chief honcho of MIT's Institute for Soldier Nanotechnologies. "The key thing from our point of view is that we gnome the problem in the news and thought maybe we could make a contribution".
Researching the issue, Radovitzky created computer models by collaborating with David Moore, a neurologist at the Defense and Veterans Brain Injury Center at Walter Reed Army Medical Center in Washington, DC Moore old MRI scans to simulate features of the brain, and the two scientists compared how the brains would reply to a frontal destroy wave in three scenarios: a head with no helmet, a head wearing the ACH, and a prime minister wearing the ACH plus a face shield. The sophisticated computer models were able to fuse the force of blast waves with skull features such as the sinuses, cerebrospinal fluid, and the layers of gray and whey-faced matter in the brain. Results revealed that without the face shield, the ACH slightly delayed the burst wave's arrival but did not significantly lessen its effect on brain tissue. Adding a face shield, however, considerably reduced forces on the brain.
In The USA Scientists Have Found The New Causes Of Glaucoma
In The USA Scientists Have Found The New Causes Of Glaucoma.
Glucosamine supplements that millions of Americans select to balm treat up on and knee osteoarthritis may have an unexpected side effect: They may increase risk for developing glaucoma, a scanty new study of older adults suggests in May 2013. Glaucoma occurs when there is an proliferation of intraocular pressure (IOP) or pressure inside the eye. Left untreated, glaucoma is one of the unsurpassed causes of blindness.
In the new study of 17 people, whose average age was 76 years, 11 participants had their optic pressure measured before, during and after taking glucosamine supplements. The other six had their liking pressure measured while and after they took the supplements. Overall, pressure inside the sidelong glance was higher when participants were taking glucosamine, but did return to normal after they stopped taking these supplements, the study showed.
So "This swatting shows a reversible effect of these changes, which is reassuring," wrote researchers led by Dr Ryan Murphy at the University of New England College of Osteopathic Medicine in Biddeford, Maine. "However, the likelihood that constant damage can result from prolonged use of glucosamine supplementation is not eliminated. Monitoring IOP in patients choosing to extend with glucosamine may be indicated".
Exactly how glucosamine supplements could affect power inside the eye is not fully understood, but several theories exist. For example, glucosamine is a harbinger for molecules called glycosaminoglycans, which may elevate eye pressure. The findings are published online May 23 as a delving letter in JAMA Ophthalmology.
Glucosamine supplements that millions of Americans select to balm treat up on and knee osteoarthritis may have an unexpected side effect: They may increase risk for developing glaucoma, a scanty new study of older adults suggests in May 2013. Glaucoma occurs when there is an proliferation of intraocular pressure (IOP) or pressure inside the eye. Left untreated, glaucoma is one of the unsurpassed causes of blindness.
In the new study of 17 people, whose average age was 76 years, 11 participants had their optic pressure measured before, during and after taking glucosamine supplements. The other six had their liking pressure measured while and after they took the supplements. Overall, pressure inside the sidelong glance was higher when participants were taking glucosamine, but did return to normal after they stopped taking these supplements, the study showed.
So "This swatting shows a reversible effect of these changes, which is reassuring," wrote researchers led by Dr Ryan Murphy at the University of New England College of Osteopathic Medicine in Biddeford, Maine. "However, the likelihood that constant damage can result from prolonged use of glucosamine supplementation is not eliminated. Monitoring IOP in patients choosing to extend with glucosamine may be indicated".
Exactly how glucosamine supplements could affect power inside the eye is not fully understood, but several theories exist. For example, glucosamine is a harbinger for molecules called glycosaminoglycans, which may elevate eye pressure. The findings are published online May 23 as a delving letter in JAMA Ophthalmology.
Testing A New Experimental Drug To Raise Good Cholesterol Level
Testing A New Experimental Drug To Raise Good Cholesterol Level.
An conjectural poison that raises HDL, or "good," cholesterol seems to have passed an sign hurdle by proving safe in preliminary trials. Although the trial was primarily designed to overlook at safety, researchers scheduled to present the finding Wednesday at the American Heart Association's annual assignation in Chicago also report that anacetrapib raised HDL cholesterol by 138 percent and slap in the face LDL, HDL's evil twin, almost in half. "We saw very encouraging reductions in clinical events," said Dr Christopher Cannon, assume command author of the study, which also appears in the Nov 18, 2010 exit of the New England Journal of Medicine.
A big study to seal the results would take four to five years to complete so the drug is still years away from market who is a cardiologist with Brigham and Women's Hospital in Boston. Other experts are intrigued by the findings, but note that the check out is still in very ahead stages. "There are a lot of people in the prevention/lipid field that are simultaneously excited and leery," said Dr Howard Weintraub, clinical concert-master of the Center for the Prevention of Cardiovascular Disease at NYU Langone Medical Center in New York City.
Added Dr John C LaRosa, president of the State University of New York (SUNY) Downstate Medical Center in New York City: "It's very prodromic but it's material because the final drug out of the barrel of this type was not a success. This looks match a better drug, but it's not definitive by any means. Don't take this to the bank".
LaRosa was referring to torcetrapib, which, get off on anacetrapib, belongs to the class of drugs known as cholesterol ester take protein (CETP) inhibitors. A large trial on torcetrapib was killed after investigators found an increased jeopardy of death and other cardiovascular outcomes. "I would be more excited about anacetrapib if I hadn't seen what happened to its cousin torcetrapib. Torcetrapib raised HDL astoundingly but that was completely neutralized by the development in cardiovascular events".
An conjectural poison that raises HDL, or "good," cholesterol seems to have passed an sign hurdle by proving safe in preliminary trials. Although the trial was primarily designed to overlook at safety, researchers scheduled to present the finding Wednesday at the American Heart Association's annual assignation in Chicago also report that anacetrapib raised HDL cholesterol by 138 percent and slap in the face LDL, HDL's evil twin, almost in half. "We saw very encouraging reductions in clinical events," said Dr Christopher Cannon, assume command author of the study, which also appears in the Nov 18, 2010 exit of the New England Journal of Medicine.
A big study to seal the results would take four to five years to complete so the drug is still years away from market who is a cardiologist with Brigham and Women's Hospital in Boston. Other experts are intrigued by the findings, but note that the check out is still in very ahead stages. "There are a lot of people in the prevention/lipid field that are simultaneously excited and leery," said Dr Howard Weintraub, clinical concert-master of the Center for the Prevention of Cardiovascular Disease at NYU Langone Medical Center in New York City.
Added Dr John C LaRosa, president of the State University of New York (SUNY) Downstate Medical Center in New York City: "It's very prodromic but it's material because the final drug out of the barrel of this type was not a success. This looks match a better drug, but it's not definitive by any means. Don't take this to the bank".
LaRosa was referring to torcetrapib, which, get off on anacetrapib, belongs to the class of drugs known as cholesterol ester take protein (CETP) inhibitors. A large trial on torcetrapib was killed after investigators found an increased jeopardy of death and other cardiovascular outcomes. "I would be more excited about anacetrapib if I hadn't seen what happened to its cousin torcetrapib. Torcetrapib raised HDL astoundingly but that was completely neutralized by the development in cardiovascular events".
Skiing Prolongs Life
Skiing Prolongs Life.
Hitting the slopes soon? A unexplored writing-room suggests that's a good idea, because skiing and snowboarding holidays can boost your overall happiness. Researchers surveyed 279 visitors at three principal ski resorts in South Korea. Of those people, 126 were skiers, 112 were snowboarders and 41 did both. Participants worn out an mean of 4,5 days at a resort, and 90 percent visited ski resorts less than five times a season.
Hitting the slopes soon? A unexplored writing-room suggests that's a good idea, because skiing and snowboarding holidays can boost your overall happiness. Researchers surveyed 279 visitors at three principal ski resorts in South Korea. Of those people, 126 were skiers, 112 were snowboarders and 41 did both. Participants worn out an mean of 4,5 days at a resort, and 90 percent visited ski resorts less than five times a season.
People Often Die In Their Sleep
People Often Die In Their Sleep.
People with doze apnea and hard-to-control drunk blood pressure may see their blood pressure drop if they treat the catnap disorder, Spanish researchers report. Continuous positive airway pressure (CPAP) is the orthodox treatment for sleep apnea, a condition characterized by disrupted breathing during sleep. The drop disorder has been linked to high blood pressure. Patients in this study were taking three or more drugs to tone down their blood pressure, in addition to having sleep apnea.
Participants who used the CPAP device for 12 weeks reduced their diastolic blood compel (the bottom number in a blood pressure reading) and improved their overall nighttime blood pressure, the researchers found. "The popularity of sleep apnea in patients with uncompliant high blood pressure is very high," said lead researcher Dr Miguel-Angel Martinez-Garcia, from the Polytechnic University Hospital in Valencia. "This forty winks apnea therapy increases the probability of recovering the normal nocturnal blood pressure pattern.
Patients with resistant great in extent blood pressure should undergo a sleep study to rule out obstructive sleep apnea, Martinez-Garcia said. "If the resolute has sleep apnea, he should be treated with CPAP and undergo blood compression monitoring". The report, published in the Dec 11, 2013 issue of the Journal of the American Medical Association, was partly funded by Philips-Respironics, maker of the CPAP combination used in the study.
The CPAP organized whole consists of a motor that pushes air through a tube connected to a mask that fits over the patient's announce and nose. The device keeps the airway from closing, and thus allows interminable sleep. Sleep apnea is a common disorder. The pauses in breathing that patients know-how can last from a few seconds to minutes and they can occur 30 times or more an hour.
People with doze apnea and hard-to-control drunk blood pressure may see their blood pressure drop if they treat the catnap disorder, Spanish researchers report. Continuous positive airway pressure (CPAP) is the orthodox treatment for sleep apnea, a condition characterized by disrupted breathing during sleep. The drop disorder has been linked to high blood pressure. Patients in this study were taking three or more drugs to tone down their blood pressure, in addition to having sleep apnea.
Participants who used the CPAP device for 12 weeks reduced their diastolic blood compel (the bottom number in a blood pressure reading) and improved their overall nighttime blood pressure, the researchers found. "The popularity of sleep apnea in patients with uncompliant high blood pressure is very high," said lead researcher Dr Miguel-Angel Martinez-Garcia, from the Polytechnic University Hospital in Valencia. "This forty winks apnea therapy increases the probability of recovering the normal nocturnal blood pressure pattern.
Patients with resistant great in extent blood pressure should undergo a sleep study to rule out obstructive sleep apnea, Martinez-Garcia said. "If the resolute has sleep apnea, he should be treated with CPAP and undergo blood compression monitoring". The report, published in the Dec 11, 2013 issue of the Journal of the American Medical Association, was partly funded by Philips-Respironics, maker of the CPAP combination used in the study.
The CPAP organized whole consists of a motor that pushes air through a tube connected to a mask that fits over the patient's announce and nose. The device keeps the airway from closing, and thus allows interminable sleep. Sleep apnea is a common disorder. The pauses in breathing that patients know-how can last from a few seconds to minutes and they can occur 30 times or more an hour.
Subscribe to:
Posts (Atom)